- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Latest News
- Contact us
The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Caroline Richards on +44 (0)1959 563311 or email us.
Posted on: 28 January 2015 | Source: Frost & Sullivan
Frost & Sullivan says existing competitors’ dominance of the niche market raises entry barriers...
Posted on: 28 January 2015 | Source: Roche
Commenting on the Group’s results, Roche CEO Severin Schwan said: “We made good progress in 2014 with solid growth in both divisions driven by our newly launched medicines and diagnostic tests..."
Posted on: 28 January 2015 | Source: The Astellas Innovation Debate
British patients happy to have webcam consultations – especially the over 55s...
Posted on: 28 January 2015 | Source: GlobalData
The acromegaly and gigantism treatment market will expand at a modest Compound Annual Growth Rate (CAGR) of 3.74% from approximately $588 million in 2013 to $707 million by 2018, limited by a sparse pipeline, according to research and consulting firm GlobalData...
Posted on: 28 January 2015 | Source: Bristol-Myers Squibb Company
Bristol-Myers Squibb Company reported results for the fourth quarter and full year of 2014, which were highlighted by strong global sales for priority brands and important advances in the company’s immuno-oncology (I-O) portfolio...
Posted on: 28 January 2015 | Source: Andrew Lloyd & Associates
ProveDye is a new sterile solution of methylene blue designed to aid visualization in surgical procedures. With ProveDye, Provepharm extends the Proveblue® methylene blue compound product range...
Posted on: 27 January 2015 | Source: Frost & Sullivan
Country-specific EHR implementation strategies will expedite market development, says Frost & Sullivan...
Posted on: 27 January 2015 | Source: Actavis
Actavis plc and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately £306 million in cash...
Posted on: 27 January 2015 | Source: Lukats and Shapiro
Half of UK bosses tempted to snoop on employees health app data to catch them ‘pulling a sickie’...
Posted on: 27 January 2015 | Source: Health Consumer Powerhouse
In spite of financial crisis, European healthcare keeps improving – but the equity gap widens...
Posted on: 27 January 2015 | Source: Moberg Pharma
Moberg Pharma AB announced that its partner, Menarini Asia-Pacific, has received approval for Moberg’s fungal nail product in China...
Posted on: 26 January 2015 | Source: Pegasus
Research shows 87% of users prefer Cetraben® Ointment compared with other widely prescribed ointments...